NuVision Biotherapies appoints Chief Executive Officer
Optics tissue-therapy company NuVision Biotherapies has named Tim Precious as its new Chief Executive Officer, effective 26th May 2026. The appointment marks a significant milestone…
News
NuVision Biotherapies strengthens board with senior appointment
Optics tissue-therapy company NuVision Biotherapies has named Joanna Underhill as its new non-executive director.Joanna will provide an integral voice at board level, working closely with…
David’s Healing Journey: Embracing Innovation with Omnigen & OmniLenz
In this touching and illuminating video, we follow David as he embarks on his healing journey with the groundbreaking ocular treatment from NuVision Biotherapies. Through…
The 5-minute eye health checklist: Quick tips for protecting your vision
Your eyes are constantly working—whether you’re staring at a screen, enjoying the sunshine, or just going about your day. But how often do you take…
Published data shows Omnigen delivers a rapid and significant benefit in dry eye disease patients
Attendees at this week’s prestigious Saudi Ophthalmology annual meeting - So2023 (link) from 19-21st October in Riyadh will learn about the latest clinical research outcomes…
NuVision Biotherapies at the ESCRS’s 41st Congress: Advancing Ophthalmic Care through Clinical Efficacy and Innovative Solutions
NuVision Biotherapies is honoured to make its inaugural appearance at the European Society of Cataract & Refractive Surgeons (ESCRS) prestigious 41st Congress, taking place in…